A Toolkit to Help Therapists Treat Mental Health Conditions in Autistic People
Tests a resource for therapists treating mental health conditions in autistic people.
Plain-language title generated from the registry record
Registry title: A Toolkit to Improve Mental Health Treatment for Autistic Individuals
Key facts
- Where
- Miami, United StatesSee the site
Where in United States
- Florida International UniversityMiami, United StatesNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Florida International University
- Trial code
- NCT07539519
- Record updated
- 10 July 2026
- Original description
This pilot study is funded by the Organization for Autism Research (OAR). We are conducting a pilot study to improve mental health treatment for autistic individuals. First, we will conduct remote focus groups to identify barriers to mental health treatment and methods to improve treatment. Based on results, we will develop a prototype of a resource for therapists. This resource will be pilot tested in a community clinic.Read full original descriptionShow less
A Transdiagnostic Toolkit to Improve Mental Health Treatment for Autistic Individuals
This pilot study is funded by the Organization for Autism Research (OAR). We are conducting a pilot study to improve mental health treatment for autistic individuals. First, we will conduct remote focus groups to identify barriers to mental health treatment and methods to improve treatment. Based on results, we will develop a prototype of a resource for therapists. This resource will be pilot tested in a community clinic.
Inclusion: A confirmed diagnosis of autism; Between 13 and 17 years old; Fluent in English; Have a co-occurring mental health condition that is appropriate for treatment at the community clinic participating in the proposed study.
Exclusion: N/A; All therapists working at the community clinic at which this study takes place will be eligible to participate.
The following describes Phase II (the clinical trial):.